Start / Reports / Health / sfao-21439

Process efficiency in the replacement of the reporting platform for therapeutic products

Federal Office for National Economic Supply

Key facts

At the end of 2021, around 11,500 human medicines were authorised in Switzerland; the uninterrupted supply of these is not guaranteed. This is not a phenomenon of the recent COVID-19 pandemic, but has been an ever-increasing concern for the therapeutic products industry, hospitals and doctors for around 20 years.